FDA expected to approve mixing and matching COVID-19 booster shots

FDA expected to approve mixing and matching COVID-19 booster shots
·2 min read

The Food and Drug Administration is predicted to announce approval for mixing and matching COVID-19 booster shots, according to the results of a recent study.

This new "mix-and-match" approach set to be announced Wednesday evening follows the findings of a National Institutes of Health study released on Oct. 13. The FDA found that recipients who had received the Johnson & Johnson single-dose vaccine and then received a Moderna vaccine showed an increase in antibody levels, the New York Times reported.

Researchers followed the antibody levels of 458 participants both two weeks and four weeks after the booster shots had been administered. Participants in the study had received one of the three vaccines authorized for emergency use at least 12 weeks prior to taking part in the study.

Researchers stressed that the study was only based on antibody levels, and it didn't account for things such as the number of immune cells, according to the outlet.

BIDEN RECEIVES COVID-19 BOOSTER SHOT ON CAMERA TO LOBBY SUPPORT FOR ROLLOUT

Additionally, the FDA is set to authorize the boosters for the Johnson & Johnson and Moderna vaccines on Wednesday, one month after the agency approved the Pfizer-BioNTech booster shoots.

Kirsten Lyke, a professor from the University of Maryland School of Medicine, stressed that the data from the study should not be used to compare which vaccine is most effective, explaining that the study "was not powered or designed to compare between groups," according to the outlet.

In late September, the FDA authorized the Pfizer-BioNTech booster vaccine to be used for seniors 65 and older.

CLICK HERE TO READ MORE FROM THE WASHINGTON EXAMINER

To date, there are currently 189.3 million people in the United States who are considered fully vaccinated. Of this group, 104.5 million have received the two-dose Pfizer-BioNTech vaccine, 69.5 million have received the two-dose Moderna vaccine, and roughly 15 million have received the Johnson & Johnson vaccine, according to the Centers for Disease Control and Prevention.

Washington Examiner Videos

Tags: News, Vaccination, Coronavirus, FDA, Healthcare

Original Author: Elizabeth Faddis

Original Location: FDA expected to approve mixing and matching COVID-19 booster shots

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting